NCT00473746 – Phase I/II Open Label Dose Escalation Study of the 17α-Hydroxylase/ C17,20-Lyase Inhibitor, Abiraterone Acetate in Hormone Refractory Prostate Cancer Posted on October 23, 2019 by tsuperadmin -
NCT00474383 – A Phase II Open Label Study of CB7630 (Abiraterone Acetate) in Patients With Advanced Prostate Cancer Who Have Failed Androgen Deprivation and Docetaxel-Based Chemotherapy Posted on October 23, 2019 by tsuperadmin -
NCT01685983 – A Phase 2 Open Label Study of Abiraterone Acetate (JNJ-212082) and Prednisolone in Patients With Advanced Prostate Cancer Who Have Failed Androgen Deprivation and Docetaxel-Based Chemotherapy. Posted on October 23, 2019 by tsuperadmin -
NCT00485303 – A Phase II Open Label Study of CB7630 (Abiraterone Acetate) and Prednisone in Patients With Advanced Prostate Cancer Who Have Failed Androgen Deprivation and Docetaxel-Based Chemotherapy Posted on October 23, 2019 by tsuperadmin -
NCT00073437 – A Multicenter, Randomized, Double-blind, Placebo-controlled Trial Evaluating the Safety and Efficacy of Infliximab (Remicade) in Subjects With Chronic Sarcoidosis With Pulmonary Involvement Posted on October 8, 2019 by tsuperadmin -
Open-label Study Exploring a Switching Regimen From Depot Neuroleptics to Risperidone Depot Microspheres Posted on August 23, 2019 by tsuperadmin -
NCT02236637 – A Prospective Registry of Patients With a Confirmed Diagnosis of Adenocarcinoma of the Prostate Presenting With Metastatic Castrate-Resistant Prostate Cancer Posted on August 12, 2019 by tsuperadmin -
NCT01989754 – A Randomized, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Canagliflozin on Renal Endpoints in Adult Subjects With Type 2 Diabetes Mellitus Posted on August 12, 2019 by tsuperadmin -
NCT01624675 – A Double-blind, Placebo-controlled Study, Followed by an Open-label Extension Study Evaluating the Efficacy and Safety of Risperidone (R064766) in Children and Adolescents With Irritability Associated With Autistic Disorder Posted on July 26, 2019 by tsuperadmin -
NCT00061802 – A Randomized, Double Blind Study to Evaluate the Efficacy and Safety of Two Atypical Antipsychotics vs. Placebo in Patients With an Acute Exacerbation of Either Schizophrenia or Schizoaffective Disorder Posted on July 26, 2019 by tsuperadmin -
The YODA Project